<DOC>
	<DOCNO>NCT02707653</DOCNO>
	<brief_summary>This study investigate use misoprostol first-line treatment incomplete abortion tertiary hospital Myanmar .</brief_summary>
	<brief_title>Sublingual Misoprostol Treatment Incomplete Abortion : Operations Research</brief_title>
	<detailed_description>This open-label feasibility study seek examine potential 400Î¼g sublingual misoprostol treatment incomplete abortion provide tertiary hospital .</detailed_description>
	<mesh_term>Abortion , Incomplete</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>1 . Confirmed incomplete abortion 2 . No known contraindication study drug 3 . Uterine size large 12 week time presentation care 4 . No sign severe infection , define least two follow : foul smell discharge , fever &gt; 38 degree C , 100 degree Fahrenheit uterine tenderness . 5 . No hemodynamic disturbance ( pulse &gt; 110/min systolic bp &lt; 100 ) 6 . General good health 7 . Agree comply study procedure include return follow visit 8 . Live work within one hour study site 9 . Willing able sign consent form 1 . Inability provide inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>